ANTARES PHARMA INC's ticker is ATRS and the CUSIP is 036642106. A total of 162 filers reported holding ANTARES PHARMA INC in Q4 2021. The put-call ratio across all filers is 0.75 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $215,000 | +437.5% | 52,383 | +362.4% | 0.00% | – |
| Q4 2021 | $40,000 | -50.6% | 11,329 | -39.2% | 0.00% | -100.0% |
| Q2 2021 | $81,000 | -57.1% | 18,631 | -59.5% | 0.00% | -50.0% |
| Q1 2021 | $189,000 | -1.0% | 46,023 | -4.0% | 0.00% | -33.3% |
| Q4 2020 | $191,000 | +33.6% | 47,952 | -9.3% | 0.00% | +50.0% |
| Q3 2020 | $143,000 | -73.2% | 52,895 | -72.7% | 0.00% | -77.8% |
| Q2 2020 | $533,000 | +248.4% | 193,692 | +198.7% | 0.01% | +125.0% |
| Q1 2020 | $153,000 | -63.8% | 64,845 | -27.9% | 0.00% | -50.0% |
| Q4 2019 | $423,000 | +763.3% | 89,975 | +457.0% | 0.01% | +300.0% |
| Q1 2019 | $49,000 | +63.3% | 16,153 | +19.5% | 0.00% | 0.0% |
| Q1 2018 | $30,000 | -72.0% | 13,513 | -74.8% | 0.00% | -66.7% |
| Q4 2017 | $107,000 | – | 53,713 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JW Asset Management, LLC | 1,671,956 | $5,384,000 | 3.43% |
| ARMISTICE CAPITAL, LLC | 5,700,000 | $18,354,000 | 2.34% |
| Rubric Capital Management LP | 3,188,600 | $10,267,000 | 2.12% |
| Broadfin Capital, LLC | 4,803,528 | $15,467,000 | 1.88% |
| THOMPSON DAVIS & CO., INC. | 192,734 | $621,000 | 1.00% |
| Asymmetry Capital Management, L.P. | 199,655 | $643,000 | 0.76% |
| Perceptive Advisors | 4,267,253 | $13,741,000 | 0.69% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 946,987 | $3,049,000 | 0.21% |
| Brown Advisory Securities, LLC | 275,000 | $886,000 | 0.20% |
| EAM Investors, LLC | 251,619 | $810,000 | 0.13% |